SLIM-K, 30 Capsules, barcode 160126417509, Distributed by: Bethel Inc.

Class I - Dangerous

What Should You Do?

  1. Check if you have this product:
    Lot # 140430; Exp.12/17
  2. Do not eat it: Even if it looks and smells fine, do not consume this product.
  3. Throw it away or return it: You can return the product to the store for a full refund.
  4. Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
  5. Report problems: Report any issues to the FDA's Safety Reporting Portal.

⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.

Recall Details

Company:
Bethel Nutritional Consulting, Inc
Reason for Recall:
Marketed Without An Approved NDA/ANDA: Product was found to contain sibutramine, desmethylsibutramine and phenolphthalein based on FDA sampling and analysis.
Classification:
Class I - Dangerous

Dangerous or defective products that predictably could cause serious health problems or death.

Status:
terminated

Product Information

Full Description:

SLIM-K, 30 Capsules, barcode 160126417509, Distributed by: Bethel Inc.

Product Codes/Lot Numbers:

Lot # 140430; Exp.12/17

Official Source

Always verify recall information with the official FDA source:

View on FDA.gov

FDA Recall Number: D-1207-2015

Related Recalls

Marketed Without An Approved NDA/ANDA: FDA analyses detected the presence of phenolphthalein, N-di-Desmethylsibutramine, and trace amounts of sibutramine and N-Desmethylsibutramine. Sibutramine and phenolphthalein were previously available drug products but were removed from the U.S. market making these products unapproved new drugs.

Aug 5, 2013 Prescription Drugs Nationwide View Details →

Marketed Without An Approved NDA/ANDA: FDA analysis detected the presence of sibutramine, N-Desmethylsibutramine and phenolphthalein. Sibutramine and phenolphthalein were previously available drug products but were removed from the U.S. market making these products unapproved new drugs.

Aug 5, 2013 Prescription Drugs Nationwide View Details →